Protective effects of cleavage agents on INS-1 cells against h-IAPP-induced apoptosis

Chemical Communications

Volumn 48, Issue 4, 2012, Pages 588-590

  Jeong, Keunhong ^a   Rim Cho, Hye ^b   Hong Choi, Seung ^b   Park, Yangki ^a   Seok Chae, Pil ^c  

^a Korea Military Academy   (South Korea)

^b Seoul National University Hospital   (South Korea)

^c Hanyang University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

2 [4 [2 [(4 BENZOOXAZOL 2 YL PHENYL)METHYLAMINO]ETHOXY] 6 (4 CHLORO BENZYLAMINO) [1,3,5]TRIAZIN 2 YLAMINO] N [3 (1,4,7,10 TETRAAZA CYCLODODEC 1 YL)PROPYL]PROPIONAMIDE; 3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; 3 [4 [2 [(4 BENZOTHIAZOL 2 YL PHENYL)METHYL AMINO]ETHOXY] 6 CYCLODO DECYLAMINO[1,3,5]TRIAZIN 2 YLAMINO] N [3 (1,4,7,10 TETRAAZA CYCLODODEC 1 YL)PROPYL]PROPIONAMIDE; AMYLIN; AMYLOID PROTEIN; ANTIDIABETIC AGENT; COBALT COMPLEX; COPPER COMPLEX; OLIGOMER; UNCLASSIFIED DRUG;

ANIMAL CELL; APOPTOSIS; ARTICLE; BIOLOGICAL ACTIVITY; CATALYSIS; CELL CULTURE; CELL PROTECTION; CELL STRAIN; CELL STRAIN HEK293; CELL STRAIN INS 1; CELL SURVIVAL; CELL VIABILITY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CYTOTOXICITY; DRUG HYDROLYSIS; IN VIVO STUDY; INCUBATION TIME; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OPTICAL DENSITY; RAT;

EID: 83455186578     PISSN: 13597345     EISSN: 1364548X     Source Type: Journal    
DOI: 10.1039/c1cc16293d     Document Type: Article

References (21)

1. P.Marchetti, M.Bugliani, R.Lupi, L.Marselli, M.Masini, U.Boggi, F.Filipponi, G.Weir, D.Eizirik, M.Cnop, Diabetologia, 2007, 50:2486-2494
2. P.Butler, J.Chou, W. B.Carter, Y. N.Wang, B. H.Bu, D.Chang, J.Chang, R.Rizza, Diabetes, 1990, 39:752
3. C. Y.Lin, T.Gurlo, R.Kayed, A. E.Butler, L.Haataja, C. G.Glabe, P. C.Butler, Diabetes, 2007, 56:1324
4. A. E.Butler, J.Jang, T.Gurlo, M. D.Carty, W. C.Soeller, P. C.Butler, Diabetes, 2004, 53:1509
5. L.Haataja, T.Gurlo, C. J.Huang, P. C.Butler, Endocr. Rev., 2008, 29:303-316
6. A. E.Butler, J.Janson, W. C.Soeller, P. C.Butler, Diabetes, 2003, 52:2304
7. J.Hu, Y. P.Yu, W.Cui, C. L.Fang, W. H.Wu, Y. F.Zhao, Y. M.Li, Chem. Commun., 2010, 46:8023-8025
8. K.Jeong, W. Y.Chung, Y. S.Kye, D.Kim, Bioorg. Med. Chem., 2010, 18:2598-2601
9. K.Jeong, W. Y.Chung, Y. S.Kye, D.Kim, S.Song, Bull. Korean Chem. Soc., 2011, 32:1751-1753
10. J.Suh, W. S.Chei, T. Y.Lee, M. G.Kim, S. H.Yoo, K.Jeong, J. Y.Ahn, JBIC, J.Biol. Inorg. Chem., 2008, 13:693-701
11. J.Suh, S. H.Yoo, M. G.Kim, K.Jeong, J. Y.Ahn, M.Kim, P. S.Chae, T. Y.Lee, J.Lee, Angew. Chem., 2007, 119:7194-7197
12. K.Jeong, M. K.Kim, W. Y.Chung, Y. S.Kye, J. H.Kim, J.Suh, J.Ind. Eng. Chem., 2009, 15:342-347
13. J. D.Green, C.Goldsbury, J.Kistler, G. J. S.Cooper, U.Aebi, J. Biol. Chem., 2004, 279:12206
14. Y.Han, C.He, M.Cao, X.Huang, Y.Wang, Z.Li, Langmuir, 2009, 26:1583-1587
15. T.Cohen, A.Frydman-Marom, M.Rechter, E. Gazit, Biochemistry, 2006, 45:4727-4735
16. W. E.Klunk, Y.Wang, G.Huang, M. L.Debnath, D. P.Holt, C. A.Mathis, Life Sci., 2001, 69:1471-1484
17. L.Ye, A.Velasco, G.Fraser, T. G.Beach, L.Sue, T.Osredkar, V.Libri, M. G.Spillantini, M.Goedert, A.Lockhart, J. Neurochem., 2008, 105:1428-1437
18. M. C.Hong, Y. K.Kim, J. Y.Choi, S. Q.Yang, H.Rhee, Y. H.Ryu, T. H.Choi, G. J.Cheon, G. I.An, H. Y.Kim, Bioorg. Med. Chem., 2010, 18:7724-7730
19. M.Shahabuddin, M.Nambiar, B.Choudhary, G. M.Advirao, S. C.Raghavan, Invest. New Drugs, 2010, 28:35-48
20. H. J.Schneider, T.Blatter, Angew. Chem., Int. Ed. Engl., 1992, 31:1207-1208
21. S.Zraika, R.Hull, C.Verchere, A.Clark, K.Potter, P.Fraser, D.Raleigh, S.Kahn, Diabetologia, 2010, 53:1046-1056